The National Institutes of Health (NIH), through its National Cancer Institute (NCI), is offering a grant opportunity titled "Microbial-based Cancer Imaging and Therapy - Bugs as Drugs," aimed at advancing research in microbial-based cancer therapies and diagnostics. This funding opportunity encourages applications that explore the interactions between microorganisms and tumors, focusing on the use of bacteria, archaebacteria, and their products for cancer imaging, therapeutics, and diagnostics, particularly in challenging cases such as oral cancer. The initiative is part of a broader effort to enhance cancer treatment methodologies and invites multidisciplinary collaborations to address limitations in traditional therapies. Interested applicants can submit proposals until May 7, 2025, with additional details available at the NIH website, and inquiries can be directed to OERWebmaster03@od.nih.gov.